Back
MoonLake Immunotherapeutics Stock Predictions
Attention Investors: The 10 Best stocks for 2025 - yours FREE
Get Your Copy of "10 Best Stocks to Own in 2025" Here.
Sell
22
MLTX
MoonLake Immunotherapeutics
Last Price:
$43.07
Seasonality Move:
11.41%
7 Day Trial
ALL ACCESS PASS
$
7
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.MoonLake Immunotherapeutics Stock Forecast
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 94.9% based on the past 4 years of stock performance.
-
MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is MoonLake Immunotherapeutics Stock Undervalued?The current MoonLake Immunotherapeutics [MLTX] share price is $43.21. The Score for MLTX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
MLTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 94.9% based on the past 4 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Sell
22
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics overpriced?
-
MoonLake Immunotherapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
61.17
52-Week Low:
37.55
Prediction Charts
Market Cap:
2.7B
Price in USD:
43.21
Volume:
231.5K
Beta:
1.29
Technical Analysis
SMA50:
48.98
SMA100:
49.64
SMA200:
46.94
52-Wk Change:
-30.86%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?Yes, MoonLake Immunotherapeutics is a publicly traded company.
-
What is the MoonLake Immunotherapeutics stock quote today?The MoonLake Immunotherapeutics stock price is 43.21 USD today.
-
How to buy MoonLake Immunotherapeutics stock online?You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-28 | 44.83 | 45.11 | 46.06 | 44.02 |
| Jan-29 | 44.88 | 46.06 | 47.28 | 44.59 |
| Jan-30 | 46.46 | 47.12 | 47.72 | 46.21 |
| Jan-31 | 47.35 | 45.99 | 47.35 | 45.26 |
| Feb-3 | 44.96 | 43.65 | 46.47 | 43.52 |
| Feb-4 | 44.40 | 44.11 | 44.40 | 42.82 |
| Feb-5 | 44.28 | 46.63 | 47.23 | 44.28 |
| Feb-6 | 46.66 | 47.11 | 48.22 | 46.08 |
| Feb-7 | 47.08 | 45.06 | 48.54 | 44.87 |
| Feb-10 | 45.18 | 44.07 | 45.68 | 44.00 |
| Feb-11 | 43.50 | 43.23 | 43.94 | 42.65 |
| Feb-12 | 42.66 | 44.27 | 44.39 | 42.40 |
| Feb-13 | 44.86 | 43.60 | 45.01 | 43.60 |
| Feb-14 | 44.60 | 43.21 | 44.60 | 42.64 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.81 per share, and a decrease next year of $0.77 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.